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Rasmussen’s aneurysm: a rare and potentially 
fatal cause of hemoptysis
Abstract
Rasmussen’s aneurysm is a rare and fatal cause of hemoptysis secondary to infection with pulmonary tuberculosis. The most 
commonly involved vessels include the bronchial arteries, but rarely can involve the pulmonary artery.
We report the case of a 62-year-old female from the Philippines with undiagnosed pulmonary tuberculosis who presented with 
massive hemoptysis. After hemodynamic stabilization, Rasmussen’s aneurysm was diagnosed by computed tomography of the 
chest with angiography, confirmed with invasive angiography. She was treated definitively with glue embolization of the affected 
artery.
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Introduction
Tuberculosis (TB), caused by the bacterium 
Mycoplasma tuberculosis, is an infectious disease 
with significant global burden, with approximate-
ly 25% of the world’s population estimated to 
be infected [1]. Multidrug resistant strains have 
become an increasing problem complicating 
treatment. In the United States, however, the in-
cidence rate of TB has been consistently declining 
for at least the past fifty years. In 2019, the United 
States’ TB rate declined to its lowest rate yet, at 
2.7 cases per 100,000 persons [2]. A large portion 
of these cases are attributed to reactivation of 
latent TB infection. Because of its low incidence 
overall in the United States, and effective screen-
ing programs in high-risk populations, significant 
complications are rarely seen. We present a case 
of a patient with a previously undiagnosed TB 
infection who suffered massive hemoptysis due to 
invasive cavitation of the pulmonary parenchyma 
with involvement of an adjacent branch of the 
pulmonary artery, a phenomenon known as the 
Rasmussen’s aneurysm.
Case presentation
A 62-year-old woman from the Philippines 
presented to the hospital with a complaint of dys-
pnea and hemoptysis. The patient initially began 
to have dyspnea at rest for several months. One 
month prior to presentation, she developed a pro-
ductive cough. The patient was diagnosed by her 
primary care provider with “acute bronchitis” 
and was first given a course of levofloxacin, then 
three courses of amoxicillin. Despite this, she 
continued to have worsening cough with blood 
noted in the sputum, prompting her to come to 
the emergency department. Her prior medical 
history included hypertension and a history of 
breast cancer on tamoxifen therapy. She also had 
a history of multiple positive purified protein 
derivative (PPD) tests for TB in the past, but with 
no formal diagnosis or treatment of latent TB.
On initial physical examination, the patient 
was dyspneic but able to speak full sentences. Her 
oxygen saturation was 95% on room air. Pulmo-
nary exam was remarkable for bilateral rhonchi to 
lung auscultation. The rest of physical exam was 
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unremarkable. While the patient was waiting in 
the emergency department, she experienced an ep-
isode of massive hemoptysis, became hypoxic, and 
then bradycardic without pulse. Advanced cardiac 
life support was initiated, and she received four 
rounds of cardiopulmonary resuscitation with 
return of spontaneous circulation. Subsequently 
she was intubated, resuscitated with fluids, and 
then started on a norepinephrine drip for shock. 
Initial laboratory workup revealed a hemoglobin 
level of 8.8 g/dL (baseline was 14 g/dL), white 
blood cell count of 19,600/mm3, and lactate of 
8.8 mmol/L. The patient was taken emergently for 
computed tomographic pulmonary angiography 
(CTPA) which showed an active pulmonary arte-
rial bleed in the left lower lobe, with an associated 
4.5 cm blood filled mass-like cavitary lesion in 
the left upper lobe in proximity with mentioned 
bleeding artery (Figures 1, 2). Invasive pulmonary 
angiography was performed confirming a large 
pseudoaneurysm arising from the proximal left 
lower lobe pulmonary artery with active bleeding 
into a cavitary lesion (Figure 3).
The patient underwent emergent glue embo-
lization with coils placed in the remnant proximal 
left lower lobar pulmonary artery (Figure 4). Spu-
tum and bronchoalveolar lavage (BAL) specimens 
were sent for acid-fast bacilli (AFB) direct and 
concentrated smears. These were positive for 
Mycobacterium tuberculosis complex without any 
drug resistance genes. The patient was started on 
a liver sparing anti-tuberculosis regimen as she 
showed evidence of acute hepatic injury, likely 
due to shock. The regimen included rifampin, 
ethambutol, and levofloxacin. She remained se-
dated and intubated for five days following the 
embolization. There were no further episodes of 
hemoptysis and her hemoglobin remained stable. 
Unfortunately, the patient was diagnosed 
with a severe anoxic brain injury as a result of 
her initial cardiac arrest. Her family requested 
a change in her goals of care to comfort care. Her 
anti-tuberculosis regimen was maintained until 
her passing for infection control purposes.
Discussion
The differential diagnosis of life-threaten-
ing hemoptysis such as in this patient includes 
bronchiectasis (particularly in cystic fibrosis), 
fungal infections, tuberculosis, malignancy, and 
vascular disorders including the vasculitides [3, 
4]. Based on our patient’s previously positive PPD 
tests, imaging studies, and the fact that the patient 
lived in an endemic country for most of her life, 
Figure 1. Coronal CT of the chest showing the mediastinal window of 
a left upper lobe cavitation in direct contact with the left lower branch 
of the pulmonary artery
Figure 2. Transverse CT of the chest showing the lung window of a 
left upper lobe cavitation in direct contact with the left lower branch 
of the pulmonary artery
there was a high suspicion that the hemoptysis 
was secondary to TB infection. Pulmonary TB 
presents with a variety of symptoms, which 
are usually insidious in onset and progression. 
Symptoms include low-grade fever, night sweats, 
cough, weight loss and mild hemoptysis that 
usually persist for weeks before patients seek 
healthcare. Rarely, patients can present with mas-
sive hemoptysis, which has a mortality rate up to 
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50%. Massive hemoptysis in tuberculosis can be 
caused by a phenomenon known as the Rasmus-
sen’s aneurysm, as was the case with our patient. 
Rasmussen’s aneurysm is a potential complication 
of chronic cavitary pulmonary disease, due to 
the invasion into the pulmonary vasculature. In 
a post-mortem analysis of patients with chronic 
cavitary tuberculosis, it has been estimated that 
up to 4% of patients had pathology consistent 
with Rasmussen’s aneurysm [4]. Of those with 
massive hemoptysis secondary to a Rasmussen’s 
aneurysm, the most commonly involved vessels 
are the bronchial arteries. In less than 10% of cas-
es, the main pulmonary artery may be involved.
Rasmussen’s aneurysm is a pseudo-aneurys-
mal dilatation of a branch of pulmonary artery 
adjacent to a tuberculous cavity that can rupture 
and cause massive hemoptysis. As a tuberculous 
cavity begins to extend into the pulmonary artery, 
granulation tissue begins to invade and replace 
the adjacent pulmonary arterial wall (specifically 
the tunica adventitia and tunica media). Fibrin 
replacement of the vessel wall leads to thinning, 
and eventually herniates into the lumen of the 
vessel creating a pseudoaneurysm [5]. This pa-
thology is reported to be associated with 5% of 
all tuberculous cavitary lesions [6]. The advent of 
contrast-enhanced CT has enabled a noninvasive, 
first-line method of localizing the site of arterial 
bleeding in the setting of massive hemoptysis, as 
seen in our case [7]. In our patient, both fiberoptic 
bronchoscopy and CTPA helped to identify the 
site of bleeding from a pulmonary artery pseudo-
aneurysm, leading to prompt intervention.
After resuscitation and stabilization of the 
patient, endovascular management techniques 
like trans-arterial catheter embolization are the 
preferred management strategy. Embolization 
techniques can include glue embolization, coil 
packaging, gel foam, detachable balloons, or 
stent grafts [6]. In Rasmussen’s aneurysm, glue 
embolization is the preferred technique due to 
the fragility of the artery [8].
Conclusions
Rasmussen’s aneurysm is a rare complication 
of pulmonary TB that can cause life-threatening 
hemoptysis, particularly in non-endemic coun-
tries. In patients presenting with massive hemop-
tysis, it is important to include in the differential 
diagnosis, and treat rapidly with embolization. 
Glue embolization is the preferred trans-cathe-




Figure 3. Angiography of the left upper lobe of the lung demonstrating 
active bleeding into the cavitary lesion
Figure 4. Post-embolization angiography of the left upper lobe of the 
lung demonstrating resolution of the bleeding pulmonary artery
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